ID: ALA1241139

Max Phase: Preclinical

Molecular Formula: C33H54ClN13O7

Molecular Weight: 780.33

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1cccc(Cl)c1)C(N)=O

Standard InChI:  InChI=1S/C33H54ClN13O7/c1-17(2)13-24(30(53)47-25(16-26(35)49)31(54)45-23(27(36)50)15-19-7-4-8-20(34)14-19)46-29(52)22(10-6-12-42-33(39)40)44-28(51)21(43-18(3)48)9-5-11-41-32(37)38/h4,7-8,14,17,21-25H,5-6,9-13,15-16H2,1-3H3,(H2,35,49)(H2,36,50)(H,43,48)(H,44,51)(H,45,54)(H,46,52)(H,47,53)(H4,37,38,41)(H4,39,40,42)/t21-,22-,23-,24-,25-/m0/s1

Standard InChI Key:  LRFOSVFQTLYKFG-KEOOTSPTSA-N

Associated Targets(Human)

CCNA2 Tchem Cyclin A2 (13 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem Cyclin-dependent kinase 2/cyclin A (2220 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 780.33Molecular Weight (Monoisotopic): 779.3958AlogP: -2.74#Rotatable Bonds: 24
Polar Surface Area: 355.48Molecular Species: BASEHBA: 9HBD: 13
#RO5 Violations: 2HBA (Lipinski): 20HBD (Lipinski): 17#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.63CX Basic pKa: 11.84CX LogP: -4.09CX LogD: -8.29
Aromatic Rings: 1Heavy Atoms: 54QED Weighted: 0.03Np Likeness Score: -0.08

References

1. Sridhar J, Akula N, Pattabiraman N..  (2006)  Selectivity and potency of cyclin-dependent kinase inhibitors.,  (1): [PMID:16584130] [10.1208/aapsj080125]

Source